Similar articles

• Placebos and sham treatments.

  Sedgwick P, Hooper C. Sedgwick P, et al. BMJ. 2015 Jul 10;351:h3755. doi: 10.1136/bmj.h3755. BMJ. 2015. PMID: 26162858 No abstract available.
• The ethical problems with sham surgery in clinical research.

  Macklin R. Macklin R. N Engl J Med. 1999 Sep 23;341(13):992-6. doi: 10.1056/NEJM199909233411312. N Engl J Med. 1999. PMID: 10498498 No abstract available.
• Placebo controls: scientific and ethical issues.

  Kowalski CJ. Kowalski CJ. Am J Bioeth. 2002 Spring;2(2):33-4. doi: 10.1162/152651602317533668. Am J Bioeth. 2002. PMID: 12189073 No abstract available.
• What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.

  Frank S, Kieburtz K, Holloway R, Kim SY. Frank S, et al. Neurology. 2005 Oct 11;65(7):1101-3. doi: 10.1212/01.wnl.0000171957.90640.b5. Epub 2005 Jul 20. Neurology. 2005. PMID: 16033990 Review.
• What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.

  Landau W. Landau W. Neurology. 2006 Jun 13;66(11):1788-9; author reply 1788-9. doi: 10.1212/01.wnl.0000230564.67320.b1. Neurology. 2006. PMID: 16769977 Review. No abstract available.